Prometrium: Clinical Trials

10 trials of Prometrium, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 2 withdrawn, 1 terminated. 10 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 5, Unknown 2, Withdrawn 2, Terminated 1
Phase 32Unknown 1, Withdrawn 1
Phase 11Terminated 1

Follow Prometrium: new trials by email Literature Review of Prometrium trials Research Report on Prometrium

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HOPE Trial hCG or Progesterone Effect on Recurrent Pregnancy Loss
Progesterone Pill, hCG - Recurrent Pregnancy Loss Without Current Pregnancy
Phase 2WithdrawnWake Forest University Health Sciences2022-05-012022-05-09
Neurobiology of Bulimia Nervosa
Estradiol, Micronized progesterone, Leuprolide Acetate - Bulimia Nervosa
Phase 2CompletedUniversity of North Carolina, Chapel Hill102020-02-242022-07-26
Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
Leuprolide Acetate 3.75 MG/ML, Estradiol 2 Mg tablet, Micronized progesterone - Perinatal Depression, Post Partum Depression
Phase 2CompletedUniversity of North Carolina, Chapel Hill232020-01-022023-08-25
Blocking Mifepristone Action With Progesterone
Mifepristone 200 MG, micronized Progesterone, Placebo oral capsule - Pregnancy, Unwanted
Phase 1 / Phase 2TerminatedUniversity of California, Davis122019-02-112020-01-22
Impact of Progesterone on Stress Reactivity and Cannabis Use
Progesterone, Placebo - Cannabis Use
Phase 2CompletedMedical University of South Carolina1482019-01-182023-09-28
Cerclage for Twins With Short Cervix
Cervical Cerclage placement, Vaginal Progesterone - Preterm Birth, Preterm Labor With Preterm Delivery, Unspecified Trimester, Fetus 2
Phase 2 / Phase 3WithdrawnPediatrix2017-10-012018-03-21
Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
17beta Estradiol, Transdermal placebo patch, Progesterone - Estrogen Deficiency, Cardiovascular Disease (CVD)
Phase 2CompletedCedars-Sinai Medical Center292017-01-012025-03-13
Progesterone Supplementation for HIV-positive Pregnant Women on Anti-Retrovirals
Prometrium - HIV-1 Infection
Phase 2UnknownMount Sinai Hospital, Canada402015-08-012015-07-30
PP13 and Doppler Study to Predict Preeclampsia
Progesterone, Low molecular weight Heparin, No Drug - Preeclampsia
Phase 2 / Phase 3UnknownBen-Gurion University of the Negev10002009-08-012009-06-25
Sex Hormones and Orthostatic Tolerance
Ganirelix acetate, 17β-Oestradiol, Progesterone - Orthostatic Intolerance
Phase 2CompletedYale University1092006-02-012018-12-13

Conditions studied

Premature Birth (2)  ·  Amenorrhea (1)  ·  Bulimia (1)  ·  Bulimia Nervosa (1)  ·  Cardiovascular Diseases (1)  ·  Depression (1)  ·  Depression, Postpartum (1)  ·  Feeding and Eating Disorders (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)  ·  Orthostatic Intolerance (1)  ·  Pre-Eclampsia (1)  ·  Uterine Cervical Incompetence (1)

Sponsors

University of North Carolina, Chapel Hill (2)  ·  Ben-Gurion University of the Negev (1)  ·  Cedars-Sinai Medical Center (1)  ·  Medical University of South Carolina (1)  ·  Mount Sinai Hospital, Canada (1)  ·  Pediatrix (1)  ·  University of California, Davis (1)  ·  Wake Forest University Health Sciences (1)  ·  Yale University (1)

Countries

United States (6)  ·  Canada (1)  ·  Israel (1)

Top investigators

Andrew Combs, MD (1)  ·  Chrisandra Shufelt, MD (1)  ·  Crystal E Schiller, PhD (1)  ·  Jessica Baker, PhD (1)  ·  Kellie Murphy, MD (1)  ·  Mitchell D Creinin, MD (1)  ·  Nina Stachenfeld, PhD (1)  ·  Noel Bairey-Merz, MD (1)  ·  Reli Hershkovitz, MD (1)  ·  Sharon Walmsley, MD (1)

Results publications

PMID 27965866, PMID 31809439, PMID 37610989

NIH funding

R01HL071159 (1), R21MH119615 (1), R21MH121726 (1), U54DA016511 (1)